MediFind
Condition

Spastic Ataxia Charlevoix-Saguenay Type

Symptoms, Doctors, Treatments, Research & More

Find a Doctor

Paola Giunti

Ucl Institute Of Neurology
Female

Bio


Paola Giunti is in London, United Kingdom. Dr. Giunti is a global expert in Spastic Ataxia Charlevoix-Saguenay Type. They have been an author on 108 peer reviewed articles and participated in 1 clinical trials in the past 15 years. In particular, they have been an author on 5 peer reviewed articles regarding Spastic Ataxia Charlevoix-Saguenay Type. Dr. Giunti's top three areas of expertise are Spinocerebellar Ataxia Type 4, Spinocerebellar Ataxia Type 5, and Spinocerebellar Ataxia Type 7.

Contact

London, ENG, GB

Latest Research


Latest Advance
Study
  • Condition: Friedreich ataxia
  • Journal: Annals of clinical and translational neurology
  • Treatment Used: omaveloxolone
  • Number of Patients: 69
  • Published —
The purpose of the study was to assess the safety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia patients.

Clinical Trials


Clinical Trial
Other
  • Status: Recruiting
  • Participants: 900
  • Start Date: May 2010
Patient Registry of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS)

All Publications
View All


Publication
Study
  • Journal: Orphanet journal of rare diseases
  • Published —
Onset features and time to diagnosis in Friedreich's Ataxia.
Publication
Study
  • Journal: Brain : a journal of neurology
  • Published —
The repeat variant in MSH3 is not a genetic modifier for spinocerebellar ataxia type 3 and Friedreich's ataxia.

Contact

London, ENG, GB

Insurance

Contact them to find out if they accept your insurance plan.